FI65912B - PROCEDURE FOR FRAMING PROCESSING OF PHARMACEUTICAL COMPOSITION INKLUSIONSKOMPLEXER AV PROSTACYKLIN OCH PROSTACYKLIN-C1-4-ESTRAR MED BETA-CYKLODEXTRIN - Google Patents

PROCEDURE FOR FRAMING PROCESSING OF PHARMACEUTICAL COMPOSITION INKLUSIONSKOMPLEXER AV PROSTACYKLIN OCH PROSTACYKLIN-C1-4-ESTRAR MED BETA-CYKLODEXTRIN

Info

Publication number
FI65912B
FI65912B FI782878A FI782878A FI65912B FI 65912 B FI65912 B FI 65912B FI 782878 A FI782878 A FI 782878A FI 782878 A FI782878 A FI 782878A FI 65912 B FI65912 B FI 65912B
Authority
FI
Finland
Prior art keywords
prostacyklin
inklusionskomplexer
cyklodextrin
estrar
och
Prior art date
Application number
FI782878A
Other languages
Finnish (fi)
Other versions
FI65912C (en
FI782878A (en
Inventor
Jozsef Szejtli
Nee Rengei Magdolna Szejtli
Gyoergy Cseh
Istvan Stadler
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI782878A publication Critical patent/FI782878A/en
Application granted granted Critical
Publication of FI65912B publication Critical patent/FI65912B/en
Publication of FI65912C publication Critical patent/FI65912C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C07D307/937Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans with hydrocarbon or substituted hydrocarbon radicals directly attached in position 2, e.g. prostacyclins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nanotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI782878A 1977-09-23 1978-09-21 PROCEDURE FOR FRAMING PROCESSING OF PHARMACEUTICAL COMPOSITION INKLUSIONSKOMPLEXER AV PROSTACYKLIN OCH PROSTACYKLIN-C1-4-ESTRAR MED BETA-CYKLODEXTRIN FI65912C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU77CI1770A HU179141B (en) 1977-09-23 1977-09-23
HUCI001770 1977-09-23

Publications (3)

Publication Number Publication Date
FI782878A FI782878A (en) 1979-03-24
FI65912B true FI65912B (en) 1984-04-30
FI65912C FI65912C (en) 1984-08-10

Family

ID=10994670

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782878A FI65912C (en) 1977-09-23 1978-09-21 PROCEDURE FOR FRAMING PROCESSING OF PHARMACEUTICAL COMPOSITION INKLUSIONSKOMPLEXER AV PROSTACYKLIN OCH PROSTACYKLIN-C1-4-ESTRAR MED BETA-CYKLODEXTRIN

Country Status (20)

Country Link
JP (1) JPS5456685A (en)
AT (1) AT369362B (en)
BE (1) BE870646A (en)
CH (1) CH637388A5 (en)
CS (1) CS200242B2 (en)
DD (1) DD138600A5 (en)
DE (1) DE2840142A1 (en)
DK (1) DK420778A (en)
FI (1) FI65912C (en)
FR (1) FR2404006A1 (en)
GB (1) GB2006193B (en)
GR (1) GR65001B (en)
HU (1) HU179141B (en)
IL (1) IL55569A (en)
IT (1) IT1160661B (en)
NL (1) NL7809643A (en)
PL (1) PL121664B1 (en)
SE (1) SE447574B (en)
SU (1) SU847914A3 (en)
YU (1) YU220678A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
JPS5920230A (en) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト Drug containing piruprophen
JPS61289034A (en) * 1985-06-17 1986-12-19 Teijin Ltd Fatty emulsion of prostaglandin i2
DE3608088C2 (en) * 1986-03-07 1995-11-16 Schering Ag Pharmaceutical preparations containing cyclodextrin clathrates of carbacyclin derivatives
DE3740838A1 (en) * 1987-11-27 1989-06-08 Schering Ag CYCLODEXTRINCLATHRATE OF 5-CYANO-PROSTACYCLINE DERIVATIVES AND THEIR USE AS MEDICINAL PRODUCTS
EP1710244A4 (en) * 2004-01-29 2009-06-17 Eisai R&D Man Co Ltd Method of stabilizing macrolide compound

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS503362B1 (en) * 1970-06-10 1975-02-04
US3953435A (en) * 1974-01-10 1976-04-27 Ono Pharmaceutical Company Aldehyde derivatives of prostaglandins
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
JPS53136513A (en) * 1977-05-06 1978-11-29 Ono Pharmaceut Co Ltd Stabilization of prostaglandin-x-related compounds

Also Published As

Publication number Publication date
GB2006193A (en) 1979-05-02
CH637388A5 (en) 1983-07-29
FI65912C (en) 1984-08-10
FI782878A (en) 1979-03-24
IL55569A (en) 1981-12-31
PL209773A1 (en) 1979-06-04
IL55569A0 (en) 1978-12-17
SU847914A3 (en) 1981-07-15
NL7809643A (en) 1979-03-27
PL121664B1 (en) 1982-05-31
DE2840142A1 (en) 1979-04-05
JPS5456685A (en) 1979-05-07
CS200242B2 (en) 1980-08-29
YU220678A (en) 1983-10-31
HU179141B (en) 1982-08-28
SE7809946L (en) 1979-03-24
AT369362B (en) 1982-12-27
BE870646A (en) 1979-01-15
IT1160661B (en) 1987-03-11
FR2404006A1 (en) 1979-04-20
GR65001B (en) 1980-06-12
ATA677478A (en) 1982-05-15
IT7869160A0 (en) 1978-09-19
DD138600A5 (en) 1979-11-14
SE447574B (en) 1986-11-24
GB2006193B (en) 1982-05-26
DK420778A (en) 1979-03-24
FR2404006B1 (en) 1981-07-31

Similar Documents

Publication Publication Date Title
FI800008A (en) FRAMEWORK FOR FRAMSTATION OF PEPTIDYLARGININALDEHYD DERIVATIVES
FI783917A (en) AMINDERIVAT DERAS FRAMSTAELLNINGSFOERFARANDE OCH DESSA INNEHAOLLANDE PHARMACEUTICAL COMPOSITION
SE7803660L (en) CEFEM DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION
SE7804185L (en) CEFEM DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION
SE7802853L (en) CEFEM DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION
RO70246A (en) PROCESS FOR THE PREPARATION OF (1-PHENYL-2-TRIAZOLLYTIL) -ETER DERIVATIVES
FI784013A (en) CONTAINING EFFECTIVE EFFECTS WITH FRAMEWORK EFFECTS FOR FRAMING PROCESSING
IT1121273B (en) SIMILAR DERIVATIVES OF CEPHALOSPORINE AND PROCEDURES FOR THEIR PREPARATION
NO781168L (en) PROCEDURES FOR THE PREPARATION OF DIASEPIN DERIVATIVES
FI781938A (en) PROCEDURE FOR THE FRAMEWORK OF FRAMSTAELLNING AV GOALDELDAECKVAEVNAD
FI781357A (en) FRAMEWORK FOR THE FRAMEWORK OF POLYURETANSKUM
SE7803035L (en) PROCEDURE FOR THE PREPARATION OF TIENOPYRIDINE DERIVATIVES
FI65912B (en) PROCEDURE FOR FRAMING PROCESSING OF PHARMACEUTICAL COMPOSITION INKLUSIONSKOMPLEXER AV PROSTACYKLIN OCH PROSTACYKLIN-C1-4-ESTRAR MED BETA-CYKLODEXTRIN
NO784382L (en) PROCEDURE FOR THE PREPARATION OF TIAZOLDIN DERIVATIVES
SE7802024L (en) PROCEDURE FOR THE PREPARATION OF PYRROLOKINOXALINONES AND PYRROLOBENZODIAZEPINONS
IT7852471A0 (en) DERIVATIVES OF 2-AMINOMETHYL-PHENOL AND PROCEDURE FOR THEIR PREPARATION
FI802867A (en) FOER REQUIREMENTS FOR FRAMING PROCESSING OF TAETADE FOERPACKNINGAR FOER UTBREDBARA PRODUKTER
RO79258A (en) PROCEDURE FOR PREPARATION OF 4 '' - AMINOYLANEANDOMICINE DERIVATIVES
SE7809935L (en) DERIVATIVES OF 2-OXAZOLIDONE AND PROCEDURES FOR THE PREPARATION OF THE SAME
SE7804141L (en) PURIFIED COMPOSITIONS OF UROKINAS AND THEIR PROCEDURE
SE432424B (en) HALOGENERED ALCOXISILAN COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION
NO780389L (en) PROCEDURE FOR THE PREPARATION OF ERYTROMYCIN DERIVATIVES
SE7805874L (en) 1-PHENYL-1-METHOXY-2-AMINO-ETHANE DERIVATIVES AND PROCEDURES FOR THEIR PREPARATION
NO783042L (en) IMPROVED PROCEDURE FOR PREPARATION OF 3-BROMOMETHYL-3-CEFEM SULFOXIDE DERIVATIVES
SE7807489L (en) PROCEDURE FOR THE PREPARATION OF AZETIDINONES

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CHINOIN GYOGUSZER ES VEGYESZETI TERMEKEK